Aldehyde reductase from ox kidney cytosol has been fractionated into four forms, two of which have been purified to apparent homogeneity. One of the minor forms is shown to be heterogenous on polyacrylamide-gel electrophoresis. The substrate specificities of the four forms using a variety of aldehydes and ketones are presented. The sensitivity of the various forms to inhibition by sodium valproate, sodium barbitone and various benzodiazepines has been determined. The relationships of these forms to the previously described hexonate dehydrogenase, aldose reductase and prostaglandin dehydrogenase is discussed.
Aldehyde reductases are NADPH-dependent oxidoreductases which reduce aldehydes to their corresponding alcohols. They possess a wide species and tissue distribution (Davidson et al., 1978) . Multiple forms of aldehyde reductase have been described in brain (Tabakoff & Erwin, 1970; Turner & Tipton, 1972; Ris & von Wartburg, 1973) and in liver (Tulsiani & Touster, 1977; Sawada et al., , 1980 Branlant & Biellmann, 1980) , while have reported multiple forms of aldehyde/ketone reductase in guinea-pig kidney.
The physiological role(s) of these multiple forms remain obscure and have been variously suggested as functioning in the catabolism of biogenic amines (Turner & Tipton, 1972; Tabakoff & von Wartburg, 1975) , the polyol pathway (Hers, 1960) , drug detoxification (Bachur, 1976) and the inactivation of prostaglandins E and F (Wermuth, 1981; Chang & Tai, 1981) . The major barbiturate-sensitive form of aldehyde reductase appears to be involved in ascorbate biosynthesis, reducing D-glucuronate to L-gulonate (Flynn et al., 1975) . Since the ascorbate biosynthetic pathway is localized in liver or kidney, depending on the species (Chatterjee, 1973) , the high levels of the major form of aldehyde reductase reported in these tissues (Davidson et al., 1978) can be interpreted as further evidence of its role in ascorbate biosynthesis.
Most aldehyde reductases, including the major form, have Mr values of approx. 30000; however, higher molecular weight forms (Mr 50000-1 10000) Abbreviation used: SDS, sodium dodecyl sulphate.
Vol. 205 have also been described (Bosron & Prairie, 1973; Cash et al., 1979; Sawada et al., 1980) .
Although the major form of aldehyde reductase has been purified and studied in detail from pig kidney (Flynn et al., 1975; Morpeth & Dickinson, 1980) , an analysis of the kinetic mechanism has been restricted to the substrates glyceraldehyde and pyridine-3-aldehyde (Davidson & Flynn, 1979; Morpeth & Dickinson, 1981) . We have purified the major form of ox kidney aldehyde reductase (since this species, unlike certain species of bats and primates, is capable of the biosynthesis of ascorbate) to enable a detailed examination of the kinetic mechanism with D-glucuronate as substrate. Details of the purification procedure are described in this paper. While this study was in progress we noted the presence of three minor forms of aldehyde reductase and this paper also presents details of their substrate specificities and inhibitor sensitivities. Aldehyde reductase activity was routinely monitored by measuring the decrease in A340 with 75pM-NADPH and either 20mM-glucuronic acid or 0.33mM-4-nitrobenzaldehyde in 0.1M-sodium phosphate buffer, pH 7.0 at 30°C. Stock solutions of 4-nitrobenzaldehyde, 4-carboxybenzaldehyde, menadione and cyclohexanone were made up in methanol. The benzodiazepines were also made up in methanol, with the exception of flurazepam which was made up in buffer. The prostaglandins were added from stock solutions in ethanol. A control experiment showed that the amounts of methanol and ethanol added did not affect activity towards D-glucuronic acid.
Experimental

Protein measurement
For routine column monitoring protein concentration was estimated by measurement of the A280. Other samples were assayed by either the biuret method (Gornall et al., 1949) or the microbiuret method of Goa (1953) . Bovine serum albumin was used as standard in both assays. (280g/A) was added slowly and the suspension was stirred for 20min. After centrifugation at 1600Og for 20min, the pellet was discarded and (NH4)2SO4 (199 g/1) was slowly added to the supernatant. After centrifugation the pellet was resuspended in a small volume of 10mM-sodium phosphate/2mM-EDTA/ 2.5 mM-2-mercaptoethanol, pH 7.2. This solution was dialysed overnight against 20 litres of the same buffer. The non-dialysable material was applied to a DEAE-cellulose column (14 cm x 7 cm) equilibrated with 10mM-sodium phosphate buffer, pH7.2, containing 2.5mM-2-mercaptoethanol. The majority of the enzyme activity did not bind to the column. Two further peaks of activity were eluted with a linear 0-0.2 M-KCI gradient (2 x 1 litre). The three peaks of activity were denoted F 1, F2 and F3 in order of their elution.
Further purification offraction Fl F I was applied to a DEAE-cellulose column (14cm x 7cm) equilibrated with 10mM-Tris/HCI, pH 7.5, containing 2.5 mM-2-mercaptoethanol. Activity was eluted with a linear 0-0.1 M-KCI gradient (2 x 1 litre). Active fractions were applied to a Procion Orange MX-G-Sepharose 4B column [Ocm x 7cm; synthesized by the method of Baird et al. (1976) ], equilibrated with 10mM-Tris/HCI, pH 7.5, containing 2.5 mM-2-mercaptoethanol. Activity was eluted with a linear 0-1M-KCI gradient (2 x 1.0 litre). Active fractions were concentrated by ultrafiltration under nitrogen in an Amicon unit equipped with a UM-10 membrane. The enzyme was then gel-filtered on a Sephadex G-100 column (2.5 cm x 90 cm), equilibrated with IOmM-Tris/HCI/ 0.1 M-KCI/2 mM-EDTA/2.5 mM-2-mercaptoethanol, pH 7.5. Active fractions were pooled, concentrated to a protein concentration of 1 mg/ml and stored at -20°C. The purified enzyme is described as AR1.
Further purification offraction F3
F3 from the DEAE-cellulose column was precipitated by addition of (NH4)2SO4 to give 85% saturation. After centrifugation at 16 000g, the pellet was resuspended in a small volume of 10mM-sodium phosphate buffer, pH 7.2, containing 2.5 mM-2-mercaptoethanol and dialysed overnight against 5 litres of the same buffer. The nondialysable material was concentrated by ultrafiltration to a volume of approx. 15ml, and applied to a Sephadex G-100 column (2.5cm x 98cm) equilibrated with 10mM-sodium phosphate/0. 1 M-KCI/2.5 mM-2-mercaptoethanol, pH 7.2. Two peaks of activity are separated by this procedure. The lower-Mr peak, AR 3, was applied to a Procion Orange MX-G-Sepharose 4B column (10cm x 2cm) equilibrated with 10mm-sodium phosphate buffer, pH 7.2, containing 2.5 mM-2-mercaptoethanol and eluted with a linear 0-1.5 M-KCI gradient (2 x 75 ml). The enzyme was diluted with 10mM-sodium phosphate buffer, pH 7.2, to give a final salt concentration of 0.1 M and applied to a 2',5 '-ADP-Sepharose column (7cm x lcm) equilibrated in 10mM-sodium phosphate buffer, pH 7.2. The enzyme did not bind to this column. Active fractions were pooled and concentrated to give a final protein concentration of approx. 1 mg/ ml. The enzyme was stored at 40C in the presence of 0.01% NaN3.
AR4, the higher-M, peak, was not purified further.
It was stable at 40C for at least 1 month.
Further purification offraction F2
F2 from the DEAE cellulose step was gel-filtered on a Sephadex G-100 column (2.5cm x 98cm) equilibrated in 10mM-sodium phosphate buffer, pH 7.2, containing 0.1M-KCI and 2.5mM-2-mercapto-ethanol. The gel-filtered enzyme (G2) was stable at 40C for approx. 2 weeks. SDS/polyacrylamide-gel electrophoresis SDS/polyacrylamide-gel electrophoresis was performed on 15% slab gels with the buffer systems of Laemmli (1970) . Bovine serum albumin, ovalbumin, chymotrypsinogen A and cytochrome c were used as Mr standards. Gels were stained with 1.25% Coomassie Blue R250 in methanol/acetic acid/water (5:1:4, by vol.) and destained in methanol/acetic acid/water (10:4:83, by vol.). Non-denaturing polyacrylamide-gel electrophoresis was performed at pH 8.9 on 7.5% rod gels by the method of Maizel (1971) . Gels were stained for protein as described above and for aldehyde reductase activity by the method of Turner & Tipton (1972) . Gels were stained for ketone reductase activity by substitution of 1ml of cyclohexanol per 10ml of assay mix for the propane-1,2 diol. Gels were stained for prostaglandin dehydrogenase activity by the method of Braithwaite & Jarabak (1975) Immunological studies Purified AR I (1 ml of 1 mg/ml) was thoroughly mixed with 1 ml of Freund's complete adjuvant by vortex-mixing for 1 h. The mixture was injected into multiple sites on the back of a New Zealand White rabbit. Further injections of 1 mg of AR1 in Freund's incomplete adjuvant and prepared as described above were carried out after 2 weeks and again after 4 weeks. Blood samples were collected by cardiac puncture from 1 week after the second injection. The blood was allowed to clot overnight at room temperature and then was centrifuged at 10OOg for 10min. The serum was stored at -200C. Crossreaction between enzyme and antibody was examined by immunodiffusion on plates coated with 1% (w/v) agarose in 0.85% (w/v) NaCl.
Results
Separation and purification of the aldehyde reductaseforms Aldehyde reductase activity from ox kidney cytosol was resolved into three peaks of activity by chromatography on DEAE-cellulose (Fig. 1) enzyme was not active with neutral sugars or with ketones. AR3 was also active with a variety of aldehydes; however, with pyridine-3-aldehyde as substrate the ratio kcat /Km is larger for AR3 than for AR1, the reverse being the case with substrates possessing carboxylic groups. AR3 is capable of reducing neutral sugars, although with xylose, ribose and arabinose nonlinear, downwardly curving double-reciprocal plots were obtained (Fig. 4) . It should be noted that double reciprocal plots obtained using AR3 with other substrates were linear. Although the G2 fraction appeared to consist of several forms, linear double reciprocal plots were obtained with a variety of substrates. This fraction appeared to be active with ketones, such as cyclohexanone and menadione, in addition to aldehydes. The G2 fraction also reduced 15-oxoprosta- glandin B1, which at a concentration of 45, M was 30% as active as 4-nitrobenzaldehyde under saturating conditions. AR4 was similar to G2 in reducing cyclohexanone and menadione; however, it was inactive with 15-oxoprostaglandin B1. The effect of sodium barbitone and sodium valproate on the activity of the various forms is summarized in Table  4 . ARI was potently inhibited by both compounds. G2 was also inhibited but to a lesser extent. AR3 was not inhibited by either compound while AR4 was slightly inhibited by sodium valproate but not by sodium barbitone. None of the forms were inhibited by the benzodiazepines, flurazepam, clonazepam or nitrazepam at any of the concentrations tested.
Mr determinations
The native Mr values of ARI, AR3, AR4 and G2 and the subunit Mr of AR1 and AR3 are summarized in Table 5 . 
Discussion
There are at least six NADPH-dependent enzymes (ARI, AR3, AR4 and the three electrophoretically separable forms in G2) which reduce aldehydes to alcohols in ox kidney. The nature of the three additional bands of activity in F2 (see Fig. 3a ) is unclear (although one is probably contamination by AR4) and will not be discussed further. These results contrast with those of previous workers who have found only one form of aldehyde reductase in pig kidney (Branlant & Biellmann, 1980; Morpeth & Dickinson, 1980) . This apparent discrepancy may be due to the relatively low activity of the minor forms or they may indeed be absent from the pig. have separated three aldehyde/ ketone reductases from guinea-pig liver and state that a similar pattern is obtained for guinea-pig kidney.
ARI appears to be similar to the aldehyde reductase previously described in pig kidney (Bosron & Prairie, 1972; Flynn et al., 1975; Morpeth & Dickinson, 1980) , to the high-Km aldehyde reductase in pig, rat and ox brain (Turner & Tipton, 1972; Rivett et al., 1981) and to hexonate dehydrogenase from rat liver (Mano et al., 1961; Mano & Shimazono, 1970) . All of these preparations have a native Mr of approx. 30 000, similar substrate specificities (including high activity with glucuronic acid) and sensitivity to sodium barbitone. The function of this form may be the reduction of D-glucuronate in the biosynthesis of ascorbic acid.
AR3 appears to be similar to the enzyme previously described as aldose reductase (Hers, 1957) . Like aldose reductase, AR3 is active with sugars and both have Mr values of approx. 30000. This enzyme has been previously found to occur in kidney papilli by Gabbay & O'Sullivan (1968) . AR3 is also similar to the low-Km aldehyde reductase described by Turner & Tipton (1972) having a Km value for 4-nitrobenzaldehyde an order of magnitude lower than that obtained with ARI. In this respect pyridine 3-aldehyde is even more discriminatory between ox kidney AR1 and AR3. 4-Carboxybenzaldehyde behaves in the reverse manner, having a lower Km for AR1. Aldose reductase has been previously reported to give non-linear LineweaverBurk plots with a variety of substrates (Dons & Doughty, 1976; Schaeff & Doughty, 1976; Crabbe & Halder, 1980; Hoffmann et al., 1980) . Ox kidney AR3 gives similar plots when xylose, ribose, arabinose or glucose are used as substrates; however, linear plots are obtained for other aldehydes such as 4-nitrobenzaldehyde and pyridine-3-aldehyde. These results suggest that different kinetic mechanisms may operate depending on the substrate used.
G2 consists of three closely related enzyme forms. Based on the results of gel electrophoresis experiments, all these forms appear to be active with aldehydes, ketones and prostaglandins. The exact nature of these forms remains unclear. However, they all appear to have similar Mr values and may be similar kinetically, since linear double-reciprocal plots were obtained for several substrates. G2 appears similar to the carbonyl reductase from human brain described by Wermuth (1981) which reduces aldehydes, ketones and prostaglandins. The carbonyl reductase was found to consist of three electrophoretically different forms which on separation were found to have similar amino acid compositions and kinetic properties. It is possible that the G2 forms are similarly related. Chang & Tai (1981) have recently suggested that prostaglandin 9-oxo reductase and 1 5-hydroxyprostaglandin dehydrogenase are minor forms of aldehyde reductase.
AR4 has a higher Mr value than the other forms and is active with aldehydes and with ketones such as cyclohexanone, but not with sugars or with 15-oxoprostaglandin B1. In this respect it is similar to the high-M, aldehyde reductase described by Bosron & Prairie (1973) and to the F4 form described by Sawada et al. (1980) .
